RHEHAB CHIMZIZI
Rhehab Chimzizi is a senior TB Global Fund Adviser in Zambia. He was an independent monitor for the Phase III TB vaccine clinical trial at the University of Muhimbili-Tanzania, which was jointly conducted with the University of Dartmouth-USA. In recent years, he has focused on supporting the Zambian government through the MOH to achieve its goal of eliminating TB by 2030. Has worked as a public health practitioner in 15 countries and has served in various technical groups, including as a member of the Technical Review Panel for the Global Fund, and of the Technical Advisory Committee on TB for the African Region Office of the WHO.
